Samsung medical center
Seoul, South Korea
NCT Number: NCT01864863
The purpose of this study is to compare the pharmacokinetics of two Traclear 62.5 mg tablets and one HGP1206 125 mg tablet in healthy male volunteers.
Looking for future studies?
Notify Me20 year–55 year
Male
Interventional
Phase 1
Seoul, South Korea
An Open-label, Randomized, Single-dose, 2-way Crossover Study to Compare the Pharmacokinetics and safety of Traclear 62.5 mg Tablets and HGP1206 125mg Tablet in Healthy Male Volunteers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One Bosentan 125 mg tablet
Other names: Bosentan 125 mg
Two Bosentan 62.5 mg tablets
Other names: Traclear 62.5 mg
Time frame: 0-24h
Time frame: 0-24h
Time frame: 0~24h
Time frame: 0~24h
Time frame: 0~24h
Hanmi Pharmaceutical Company Limited
Industry
An Open-label, Randomized, Single-dose, 2-way Crossover Study to Compare the Pharmacokinetics of Traclear 62.5 mg 2 Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03893500
Hypertension, Pulmonary, Lung Diseases
Stanford, California, United States
View Trial DetailsNCT05679570
Hypertension, Pulmonary, Lung Diseases
Kagoshima, Kagoshima-ken, Japan
View Trial DetailsNCT04266197
Hypertension, Pulmonary, Lung Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT02845518
Cardiovascular Diseases, Hypertension
Vandœuvre-lès-Nancy, France
View Trial Details